other material
confidence high
sentiment positive
materiality 0.55
OptimizeRx authorizes $20M share repurchase program through May 2023
OptimizeRx Corp
- Board authorized repurchase of up to $20M of outstanding common stock.
- Repurchases may occur in open market or private transactions; program expires May 17, 2023 or when $20M is reached.
- Company will finance buybacks using available cash and cash equivalents.
- Board may modify, suspend, extend or terminate the program at any time.